Table 6.
Effect of methionine and vitamin B‐complex on hematological parameters at 2 months of antituberculosis treatment
| Control group a | Test group b | P‐value a versus b | |
|---|---|---|---|
| ESR (mm/h) | 45 (IQR: 35.00–60.00) | 32 (IQR: 26.00–38.00) | <0.001a |
| WBC (x109/L) | 5.2 (IQR: 4.15–6.75) | 4.41 (IQR: 3.30–5.86) | 0.013a |
| RBC (x1012/L) | 4.3 (IQR: 4.02–5.02) | 4.66 (IQR: 4.13–5.12) | 0.070 |
| HGB (g/dL) | 11.6 (IQR: 10.45–13.25) | 12.5 (IQR: 10.90–13.60) | 0.970 |
| PCV (x103 μL) | 36.2 (IQR: 33.30–40.25) | 38 (IQR: 33.80–41.90) | 0.117 |
| PLT (x103/L) | 293 (IQR: 231.50–405.50) | 275 (IQR: 211.00–380.00) | 0.358 |
| NEUT (×109/L) | 2.7 (IQR: 2.05–4.25) | 2.34 (IQR: 1.71–3.70) | 0.103 |
| NEUT (%) | 55.7 (IQR: 44.65–63.85) | 52.5 (IQR: 44.10–61.90) | 0.330 |
| LYMPH (%) | 33.2 (IQR: 24.85–44.45) | 34.6 (IQR: 24.90–45.40) | 0.825 |
| LYMPH (×109/L) | 1.8 (IQR: 1.33–2.30) | 1.5 (IQR: 1.20–2.05) | 0.009a |
| MCV (fL) | 81.4 (IQR: 76.50–89.25) | 81.9 (IQR: 76.40–88.30) | 0.982 |
| MCH (pg) | 26.8 (IQR: 24.50–28.70) | 27.2 (IQR: 24.40–28.70) | 0.993 |
| MCHC (g/dL) | 31.5 (IQR: 30.60–32.80) | 31.9 (IQR: 30.40–34.00) | 0.653 |
a
Mann Whitney U test (Significant); IQR, Interquartile range.